FDA Panel Unanimously Supports Berlin Heart's Excor Pediatric VAD
This article was originally published in The Gray Sheet
Following strong support from an FDA advisory panel, Berlin Heart is hoping for humanitarian device approval of its Excor Pediatric ventricular assist device within the next six months.
You may also be interested in...
Berlin Heart’s Excor Pediatric ventricular assist device gains FDA humanitarian device exemption approval. Cerevast Therapeutics gains CE mark for Clotbust ER ultrasound device to treat ischemic strokes. More new products.
Boston Sci: investment grade
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.